newsfilter
← Latest News
PR Newswire·

Calliditas Therapeutics' 2023 Annual Report Published

Calliditas Therapeutics AB (NASDAQ: CALT), (NASDAQ STOCKHOLM: CALTX) ("Calliditas") today announces that the Annual Report for 2023 now is available...